Authors, year | (1) Period 1 | (2) Period 2 | (2)/(1) | ||||||
---|---|---|---|---|---|---|---|---|---|
(Location) | Myopathy | No | Rate | No | Rate | RR | (95% CI) | ||
Li et al., 2020a [6] | Dermatomyositis | 70 | 80.1 | 73 | 51.3 | 0.64 | (0.46–0.89) | ||
(BC, Canada) | Polymyositis | 79 | 58.6 | 81 | 35.4 | 0.60 | (0.44–0.82) | ||
D’Silva et al., 2021b [9] | Dermatomyositis | 33 | 71.5 | 33 | 49.1 | 0.69 | (0.42–1.11) | ||
(United Kingdom) | Polymyositis | 23 | 42.1 | 25 | 34.4 | 0.82 | (0.46–1.42) |